The administration of phosphatidic acid to rat livers perfused with media containing either 1.3 mm-or 10 ftM-Ca2" was followed by a stimulation of Ca2" efflux, 02 uptake and glucose output. The responses elicited by 100 /M-phosphatidic acid were similar to those induced by the z-adrenergic agonist phenylephrine. Contrary to suggestions that phosphatidic acid acts like a Ca2+-ionophore, no net influx of Ca2" was detected until the phosphatidic acid was removed. Sequential infusions of phenylephrine and phosphatidic acid indicate that the two agents release Ca2l from the same intracellular source. The co-administration of glucagon (or cyclic AMP) and phosphatidic acid, and also of glucagon and arachidonic acid, led to a synergistic stimulation of Ca2+ uptake of the liver, a feature similar to that observed after the coadministration of glucagon and other Ca2+-mobilizing hormones [Altin & Bygrave (1986) Biochem. J. 238, 653-661]. A notable difference, however, is that the synergistic stimulation of Ca2+ uptake induced by the co-administration of glucagon and arachidonic acid was inhibited by indomethacin, whereas that induced by glucagon and phosphatidic acid, or glucagon and other Ca2+-mobilizing agents, was not. The results suggest that the synergistic action of glucagon and arachidonic acid in stimulating Ca21 influx is mediated by prostanoids, but that of glucagon and phosphatidic acid is evoked by a mechanism similar to that of Ca2+-mobilizing agents.
INTRODUCTION
Until recently, neither phosphatidic acid nor arachidonic acid has been implicated in the mechanism of receptor-induced Ca21 mobilization, at least in the perfused rat liver, although each may be produced either directly or indirectly as a consequence of a receptorinduced activation of phospholipase C and phospholipase A2 respectively. Exogenously added phosphatidic acid has been reported to increase cellular Ca2' and to evoke various physiological responses in cells (e.g. Barritt et al., 1981; Ohsako & Deguchi, 1981) . These effects often have been explained in terms of the findings that phosphatidic acid displays Ca2+-ionophoretic properties in some systems (Tyson et al., 1976; Putney et al., 1980; Serhan et al., 1981; Harris et al., 1981) . This has led to suggestions that phosphatidic acid may be involved in mediating the influx of Ca2" induced by Ca2+-mobilizing hormones (e.g. Putney et al., 1980; Harris et al., 1981) . More recently, however, Moolenaar et al. (1986) have reported that, in human A341 carcinoma cells, phosphatidic acid elicits its effects by triggering the breakdown of phosphoinositides and releasing Ca21 from intracellular stores, and not by stimulating Ca21 influx. On the other hand, although it is well established that arachidonic acid can be metabolized to eicosanoids in many cell types (for reviews, see Decker, 1985; Needleman et al., 1986) , other reports suggest that arachidonic acid also has a potency similar to that of inositol 1,4,5-trisphosphate in releasing Ca2" from the endoplasmic reticulum in permeabilized pancreatic-islet cells (Wolf et al., 1986) , and is able to mobilize cellular Ca21 in rat islets of Langerhans (Metz et al., 1987) . In addition, we have shown that the administration of exogenous arachidonic acid to the perfused rat liver induces vasoconstriction, Vol. 247 Ca2"-flux changes and glycogenolysis (Dieter et al., 1987a,b) .
Ca2"-mobilizing agents such as phenylephrine, vasopressin, angiotensin, ADP, ATP and epidermal growth factor have been shown to interact synergistically with glucagon in stimulating Ca2" uptake by the perfused rat liver (Altin & Bygrave, 1986 . It therefore seemed important to test the possibility that in this system phosphatidic acid and arachidonic acid might similarly interact with glucagon (or cyclic AMP). We have examined this question in the present work, and report that phosphatidic acid and arachidonic acid each interacts synergistically with glucagon in stimulating Ca2l influx by the perfused rat liver. In contrast with the influx of Ca2" induced by glucagon and phosphatidic acid (and other Ca2+-mobilizing agents), which is unaffected by indomethacin, that induced by the coadministration of glucagon and arachidonic acid is inhibited by this agent. This suggests that the mode of action of phosphatidic acid is similar to that of other Ca2+-mobilizing hormones, but that the effects of arachidonic acid are mediated by products of cyclooxygenase.
METHODS AND MATERIALS
Male Wistar-strain rats (body wt. 280-350 g) fed ad libitum were used for all experiments. The rats were anaesthetized with sodium pentobarbitone (50 mg/kg) and the livers were perfused with Krebs-Henseleit (1932) bicarbonate medium, equilibrated with 02/CO2 (19:1), containing 1.3 mM-Ca2+ as described in Reinhart et al. (1982a) . The perfusate Ca2+ and 02 concentrations were monitored continuously with a Ca2+-selective electrode and a Clark-type oxygen electrode respectively, exactly as described previously (Reinhart et al., 1982a; Altin & Bygrave, 1985) . After a pre-perfusion period of 15-20 min, hormones and/or phosphatidic acid or arachidonic acid were administered at the specified concentrations by appropriate infusions with a pump-driven syringe for the period indicated in the Figures. Stock solutions of hormones were made up in Krebs-Henseleit medium, whereas phosphatidic acid and arachidonic acid were each made up in Krebs-Henseleit medium containing 10% (w/v) fatty acid-free bovine serum albumin and sonicated for 2-3 min at 37 'C. Indomethacin (20 ItM) was dissolved in dimethyl sulphoxide and then administered by addition to perfusion medium containing also 0.1 % (w/v) bovine serum albumin. Under these conditions the presence of bovine serum albumin (final concn. < 0.03 %) and dimethyl sulphoxide (final concn. < 0.02 % v/v) did not induce any significant Ca2"-flux change, nor alter significantly the responses induced by Ca2l-mobilizing agents. For some experiments the samples of the effluent perfusate were collected for glucose determination by the glucose oxidase method as described by Reinhart et al. (1982b) . Chemicals and materials Natural L-a-phosphatidic acid from egg yolk, synthetic L-a-phosphatidic acid (dipalmitoyl, dilauroyl and distearoyl 
RESULTS
Effect of phosphatidic acid administration on Ca2"-flux changes, respiratory and glycogenolytic responses Previous studies on the effect of phosphatidic acid on Ca2" fluxes in isolated cells have provided conflicting results. For example, Barritt et al. (1981) reported that phosphatidic acid stimulates the net influx of Ca2" in isolated hepatocytes, but more recently Moolenaar et al. (1986) have reported that phosphatidic acid stimulates Ca2" efflux in human A341 cells. To our knowledge, no effect of phosphatidic acid on Ca2"-flux movements in the perfused rat liver has yet been reported. As a prelude to studying possible synergistic actions of phosphatidic acid and glucagon, it therefore seemed relevant to examine first the effects ofphosphatidic acid administered alone on Ca2"-flux changes and other physiological responses in the perfused rat liver.
Figs. 1(a), 1(b) and 1(c) extracellular Ca2l concentration is lowered to 10 /M. In these experimental conditions the respiratory and glycogenolytic responses are transient (see Figs. lb and lc) . These data suggest that the influx of extracellular Ca2l is not required for triggering the induced respiratory and glycogenolytic effects, but that phosphatidic acid elicits these effects by releasing Ca2l from intracellular stores.
The data in Fig. 2(a) show that the pre-administration of phenylephrine (5 /LM) results in a marked decrease in the Ca2" efflux induced by phosphatidic acid. Also, the data in Fig. 2 (Dieter et al., 1987a,b) . Because glucagon has been found to interact synergistically with Ca2"-mobilizing agents in stimulating Ca2l influx in isolated hepatocytes (Morgan et al., 1983; Mauger et al., 1985; Poggioli et al., 1986) , and in the perfused liver (Altin & Bygrave, 1986 , we conducted experiments to determine whether such Vol. 247 Fig. 4 . Dose-response for the stimulation of Ca2' influx by the co-administration of glucagon with phosphatidic acid or with arachidonic acid Experiments were conducted exactly as described in the legend to Fig. 3(b) , except that the concentrations of phosphatidic acid and arachidonic acid were varied. For each experiment the total net amount of Ca2+ influx, as represented by the area above the curve constituting the Ca2+-influx response, was determined. Each point represents the net amount of Ca2+ influx obtained from separate experiments conducted at the indicated concentration of phosphatidic acid (PA; K) and arachidonic acid (AA; @). Each point is the mean + S.E.M. of either three or four independent experiments conducted at the indicated concentration.
synergism could be observed also with glucagon and phosphatidic acid, or glucagon and arachidonic acid. Fig. 3(a) shows the Ca2l-flux response induced by the administration of phosphatidic acid, arachidonic acid, and phenylephrine, when each was administered alone. By comparison, the effect of a 4 min pre-administration of 10 nm-glucagon is shown in Fig. 3(b) . In each instance the administration of 10 nM-glucagon leads to a synergistic stimulation of Ca2l uptake by the liver upon subsequent administration of 150 ftM-phosphatidic acid, 200 ,sM-arachidonic acid or 2 4aM-phenylephrine. Under these conditions, glucagon itself did not stimulate any net influx of Ca2" when administered alone for the 9 min period (results not shown). The Ca2l response induced by the co-administration of glucagon and phenylephrine was described previously (Altin & Bygrave, 1986) and is included here for comparison. The Ca2l influx induced by the co-administration of glucagon and arachidonic acid was essentially complete after 5 min. However, the rate of Ca2l influx induced by glucagon and phosphatidic acid (and also that induced by glucagon and phenylephrine) was approx. 60 % of maximal at 5 min of co- from the maximum deflection of the pen in the Ca2+ trace, and the net amount of Ca2+ influx from the area above the curve in the Ca2+-influx response. Liver perfusions and other details are exactly as described in the legend to Fig. 3(b administration, and the rate then decreased rapidly (within 1-2 min) when the stimuli were removed (Fig. 3) .
In each instance removal of the stimuli was subsequently followed by a slower efflux of Ca2" over a period of 20-25 min. Although the magnitude of the Ca2" influx and the minimal dose required to elicit the effect are different for each agent, the Ca2"-flux response is qualitatively similar to that induced by glucagon and phenylephrine (Fig. 3) , and glucagon and other Ca2+-mobilizing agents such as vasopressin, angiotensin, ADP, ATP and epidermal growth factor (Altin & Bygrave, 1986 . The dose-response curves for the stimulation of Ca2" uptake by glucagon and phosphatidic acid, and glucagon and arachidonic acid, are shown in Fig. 4 . With 10 nmglucagon, near-maximal stimulation of Ca2" influx occurs at 150 /SM-phosphatidic acid and 200 #M-arachidonic acid. The net amount of Ca2" uptake, and the maximum rate of Ca2l influx that is observed after the administration of these concentrations of phosphatidic acid and arachidonic acid, are given in Table 1 for comparison with phenylephrine. It is noteworthy that the Ca2" response induced by the co-administration of glucagon and phosphatidic acid, or glucagon and phenylephrine, could be repeated by a second administration of these agents after a rest period of 20-25 min. However, the Ca2+-influx response induced by glucagon and arachidonic acid was whether the cyclo-oxygenase inhibitor indomethacin could prevent the synergistic effects of glucagon and arachidonic acid (and perhaps glucagon and phosphatidic acid, or glucagon and phenylephrine) in stimulating Ca2" uptake by the liver. Figs. 5(a) and 5(b) show that a 15 min pre-treatment with 20 /SM-indomethacin results in a complete inhibition of the Ca2' response induced by the co-administration of glucagon and arachidonic acid. However, the Ca2+ influx response induced by the coadministration of glucagon and phosphatidic acid, and glucagon and phenylephrine, is not significantly affected by indomethacin (inhibition approx. 10 %). These data suggest that cyclo-oxygenase products are the active metabolites in mediating the synergistic stimulation of Ca2" influx by glucagon and arachidonic acid. The data also indicate, by contrast, that such products are unlikely to be involved in the stimulation of Ca2l influx that is induced by the co-administration of glucagon and phosphatidic acid, or glucagon and phenylephrine (see Fig. 5 ). Similarly, indomethacin failed to prevent Ca2l influx induced by the synergistic action of glucagon with vasopressin and angiotensin instead of phenylephrine (results not shown).
DISCUSSION
This work has shown that the administration of exogenous phosphatidic acid induces Ca2l efflux, and stimulates 02 uptake and glucose output in the perfused rat liver. These effects, which are observed at both 1.3 mM and 10 /M extracellular Ca2+, are consistent with reports that phosphatidic acid induces glycogenolytic effects in isolated hepatocytes (Barritt et al., 1981) and physiological responses in other cells (Salmon & Honeyman, 1980; Harris et al., 1981 ; Ohsako & Deguchi, 1981) . The results are not consistent, however, with reports that phosphatidic acid fails to stimulate glycogenolysis in cultured rat hepatocytes (Osugi et al., 1984) . It has been reported that phosphatidic acid stimulates Ca21 influx in cells in a Ca2+-ionophoretic-like action (Putney et al., 1980; Serhan et al., 1981; Harris et al., 1981; Ohsako & Deguchi, 1981) . In the perfused liver, however, the net effect of phosphatidic acid is to induce Ca2' efflux, most probably from the same intracellular stores as that released by the a-adrenergic agonist phenylephrine and other Ca2+-mobilizing hormones (see Fig. 2 ). It is noteworthy also that Holmes & Yoss (1983) failed to observe Ca21 influx-induced by phosphatidic acid, albeit in phosphatidylcholine-containing membrane vesicles. Our result is also in agreement with the observation that at early times phosphatidic acid induces a loss of 45Ca2+ from isolated hepatocytes preequilibrated with the radioisotope (Barritt et al., 1981) . Moreover, our data suggest that the action of phosphatidic acid with respect to mobilization of Ca2' and the induction of respiratory and glycogenolytic effects in liver is similar to that of phenylephrine, an agent known to induce its effects by releasing Ca2+ through the breakdown of phosphoinositides and the generation of inositol 1 ,4,5-tris-phosphate (reviewed by Reinhart et al., 1984; Berridge, 1984; Exton, 1985; Williamson et al., 1985) . The data presented thus give support to the findings by Moolenaar et al. (1986) that phosphatidic acid induces Ca2' effiux and the breakdown of phosphoinositides in human A431 carcinoma cells.
It is not yet clear whether phosphatidic acid is acting through some receptors on the surface of the plasma membrane, or whether it enters the cell and activates phospholipase C directly, as proposed by Moolenaar et al. (1986) . It is noteworthy, however, as also reported by Moolenaar et al. (1986) Altin & Bygrave, 1986 . However, the potency of phosphatidic acid differs from that of arachidonic acid in inducing Ca2l influx when each is co-administered with glucagon (see Fig. 4 ), and the maximum amount of Ca2l influx that is induced also differs between the two acids ( Fig. 3 and Table 1 ).
Our finding that phosphatidic acid induces Ca2" efflux even at low extracellular [Ca2"] (Figs. 1 and 2 of the present work), supports the observations that phosphatidic acid induces its effects by stimulating the breakdown of phosphoinositides (Moolenaar et al., 1986) . We therefore suggest that the synergistic action of glucagon and phosphatidic acid in stimulating Ca2" influx need not involve phosphatidic acid itself, but that the Ca2" influx is probably regulated by a mechanism similar to that which exists between cyclic AMP and other Ca2l-mobilizing agents which are known to stimulate phosphoinositide metabolism. The particular aspect of phosphoinositide metabolism involved in regulating Ca2" influx remains to be determined, although there is evidence for a possible involvement of inositol 1,3,4,5-tetrakisphosphate, a metabolite of inositol 1,4,5-trisphosphate (Irvine & Moor, 1986) . We are mindful, on the other hand, that phosphatidic acid is rapidly produced as a consequence of the activation of receptors linked with the breakdown of phosphoinositides and mobilization of cellular Ca2l (Berridge, 1984; Godfrey & Putney, 1984; Seyfred & Wells, 1984) , and that the temporal accumulation of phosphatidic acid in the plasma membrane of hepatocytes stimulated with vasopressin (Seyfred & Wells, 1984) correlates well with the onset of Ca2l influx that is observed in the presence of glucagon or cyclic AMP (see Altin & Bygrave, 1986) .
A further and significant feature of the synergistic interaction of glucagon and arachidonic acid in stimulating Ca2l influx is its sensitivity to the cyclo-oxygenase inhibitor indomethacin (Fig. 5 ). This suggests that arachidonic acid itself is not the active agent that interacts with glucagon (or cyclic AMP) to stimulate Ca2" influx. Rather, it would seem that metabolites of cyclo-oxygenase activity are involved in mediating this effect. By contrast, under otherwise identical conditions the synergistic stimulation of Ca2l influx induced by the co-administration of glucagon and phosphatidic acid, or glucagon and other Ca2l-mobilizing agents, is essentially unaffected by indomethacin (see Fig. 5 ). This therefore suggests that products of cyclo-oxygenase are unlikely to be involved in eliciting the synergistic effects induced by these agents.
Because the liver parenchyma are thought not to be significant producers of prostanoids (Decker, 1985; Tran-Thi et al., 1986) , it would seem that the action of arachidonic acid in liver may involve the production of prostanoids by cell types other than hepatocytes. We envisage that such prostanoids, once released from these cells, could interact with hepatocytes through receptors that are themselves linked to the breakdown of phosphoinositides and a mobilization of cellular Ca2", in a manner that is similar to that induced by Ca2"-mobilizing hormones (Creba et al., 1983; Berridge, 1984) . The synergism that exists between glucagon and arachidonic acid (Fig. 3) could then be explained by a mechanism analogous to that which exists between glucagon and the Ca2+-mobilizing hormones. This notion is consistent with our proposal that the physiological responses induced by arachidonic acid and zymosan (Dieter et al., 1987a,b) and platelet-activating factor are mediated by prostanoids produced and released by different cell types within the liver.
Thus the present work has shown that both phosphatidic acid and arachidonic acid, metabolites that are produced as a consequence of the activation of a number of different receptors, themselves elicit Ca2"-flux changes and physiological responses when administered exogenously to the perfused rat liver. Our data are consistent with the effects of arachidonic acid being mediated by products of cyclo-oxygenase, whereas those of phosphatidic acid appear to be induced by a mechanism similar to that of other Ca2l-mobilizing agents. The particular product(s) of cyclo-oxygenase involved in mediating the effects of arachidonic acid, and the mechanism by which phosphatidic acid seemingly stimulates phosphoinositide breakdown, remain to be determined.
